Fulgent Genetics Change in Accounts Payable 2015-2025 | FLGT

Fulgent Genetics change in accounts payable from 2015 to 2025. Change in accounts payable can be defined as the increase or decrease in trade payables for the given period.
Fulgent Genetics Annual Change in Accounts Payable
(Millions of US $)
2024 $3
2023 $-7
2022 $-25
2021 $-12
2020 $23
2019 $0
2018 $0
2017 $0
2016 $1
2015 $0
2014 $0
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.654B $0.283B
Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.412B 59.05
Tempus AI (TEM) United States $12.731B 0.00
Doximity (DOCS) United States $12.055B 53.63
Hims & Hers Health (HIMS) United States $9.805B 80.33
IRhythm Technologies (IRTC) United States $5.243B 0.00
Hinge Health (HNGE) United States $4.466B 0.00
Inspire Medical Systems (INSP) United States $2.752B 40.46
Privia Health (PRVA) United States $2.596B 192.27
Heartflow (HTFL) $2.379B 0.00
Enovis (ENOV) United States $1.715B 9.06
10x Genomics (TXG) United States $1.663B 0.00
Phreesia (PHR) United States $1.648B 0.00
Omnicell (OMCL) United States $1.458B 28.10
Schrodinger (SDGR) United States $1.425B 0.00
Azenta (AZTA) United States $1.365B 59.54
Clover Health Investments (CLOV) United States $1.302B 0.00
Claritev (CTEV) United States $1.088B 0.00
Evolent Health (EVH) United States $1.052B 0.00
Zepp Health (ZEPP) Netherlands $0.568B 0.00
Veradigm (MDRX) United States $0.531B 0.00
Standard BioTools (LAB) United States $0.470B 0.00
Talkspace (TALK) United States $0.430B 128.50
Butterfly Network (BFLY) United States $0.355B 0.00
Carlsmed (CARL) United States $0.320B 0.00
TruBridge (TBRG) United States $0.291B 51.03
SOPHiA GENETICS SA (SOPH) Switzerland $0.242B 0.00
Outset Medical (OM) United States $0.237B 0.00
Nyxoah SA (NYXH) Belgium $0.216B 0.00
Health Catalyst (HCAT) United States $0.205B 0.00
KORU Medical Systems (KRMD) United States $0.192B 0.00
CapsoVision (CV) United States $0.184B 0.00
MDxHealth SA (MDXH) Belgium $0.139B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.133B 0.00
CareCloud (CCLD) United States $0.112B 5.08
American Well (AMWL) United States $0.111B 0.00
EUDA Health Holdings (EUDA) Singapore $0.077B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.072B 0.00
111 (YI) China $0.063B 0.00
Pulmonx (LUNG) United States $0.062B 0.00
P3 Health Partners (PIII) United States $0.053B 0.00
HeartBeam (BEAT) United States $0.039B 0.00
Precipio (PRPO) United States $0.024B 0.00
Zhongchao (ZCMD) China $0.022B 0.00
Healthcare Triangle (HCTI) United States $0.017B 0.00
Bullfrog AI Holdings (BFRG) United States $0.012B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
HeartSciences (HSCS) United States $0.009B 0.00
Strata Skin Sciences (SSKN) United States $0.007B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Movano (MOVE) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
MSP Recovery (MSPR) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
PROFUSA (PFSA) United States $0.003B 0.00